Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q

被引:0
作者
Anemone Finck
Jos W M Van der Meer
Alejandro A Schäffer
Jessica Pfannstiel
Claire Fieschi
Alessandro Plebani
A David B Webster
Lennart Hammarström
Bodo Grimbacher
机构
[1] University Hospital Freiburg,Department of Medicine, Division of Rheumatology and Clinical Immunology
[2] Center for Infectious Diseases,Department of Medicine and Nijmegen University
[3] National Center for Biotechnology Information,Department of Health and Human Services
[4] National Library of Medicine,Department of Pediatrics and Institute of Medicine ‘Angelo Novicelli’
[5] National Institutes of Health,Department of Clinical Immunology
[6] Hôpital Saint-Louis,Department of Medicine, Division of Clinical Immunology
[7] Center Hayem,undefined
[8] University of Brescia,undefined
[9] Royal Free Hospital,undefined
[10] Karolinska Institute at Huddinge,undefined
来源
European Journal of Human Genetics | 2006年 / 14卷
关键词
common variable immunodeficiency; recurrent infections; IgA deficiency; linkage analysis; primary immunodeficiency disorder; chromosome 4;
D O I
暂无
中图分类号
学科分类号
摘要
The phenotype of common variable immunodeficiency (CVID) is characterized by recurrent infections owing to hypogammaglobulinemia, with deficiency in immunoglobulin (Ig)G and at least one of IgA or IgM. Family studies have shown a genetic association between CVID and selective IgA deficiency (IgAD), the latter being a milder disorder compatible with normal health. Approximately 20–25% of CVID cases are familial, if one includes families with at least one case of CVID and one of IgAD. Nijenhuis et al described a five-generation family with six cases of CVID, five cases of IgAD, and three cases of dysgammaglobulinemia. We conducted a genome-wide scan on this family seeking genetic linkage. One interval on chromosome 4q gives a peak multipoint LOD score of 2.70 using a strict model that treats only the CVID patients and one obligate carrier with dysgammaglobulinemia as affected. Extending the definition of likely affected to include IgAD boosts the peak multipoint LOD score to 3.38. The linkage interval spans at least from D4S2361 to D4S1572. We extended our study to a collection of 32 families with at least one CVID case and a second case of either CVID or IgAD. We used the same dominant penetrance model and genotyped and analyzed nine markers on 4q. The 32 families have a peak multipoint LOD score under heterogeneity of 0.96 between markers D4S423 and D4S1572 within the suggested linkage interval of the first family, and an estimated proportion of linked families (α) of 0.32, supporting the existence of a disease-causing gene for autosomal-dominant CVID/IgAD on chromosome 4q.
引用
收藏
页码:867 / 875
页数:8
相关论文
共 50 条
[41]   Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1-1q25.3 region [J].
Al-Ali, Faiza Mohamed Saleh ;
Ratnamala, Uppala ;
Mehta, Timir Y. ;
Naveed, Mohammad ;
Al-Ali, Mahmoud T. ;
Al-Khaja, Najib ;
Sheth, Jayesh J. ;
Master, Dilipkumar C. ;
Maiti, Amit K. ;
Chetan, Ghati K. ;
Nath, Swapan K. ;
Radhakrishna, Uppala .
EXPERIMENTAL DERMATOLOGY, 2010, 19 (09) :851-853
[42]   A novel locus DFNA59 for autosomal dominant nonsyndromic hearing loss maps at chromosome 11p14.2-q12.3 [J].
Chatterjee, Arunima ;
Jalvi, Rajeev ;
Pandey, Nishtha ;
Rangasayee, R. ;
Anand, Anuranjan .
HUMAN GENETICS, 2009, 124 (06) :669-675
[43]   X-CHROMOSOME INACTIVATION ANALYSIS TO DISTINGUISH SPORADIC CASES OF X-LINKED AGAMMAGLOBULINEMIA FROM COMMON VARIABLE IMMUNODEFICIENCY [J].
TSUGE, I ;
MATSUOKA, H ;
ABE, T ;
KAMACHI, Y ;
TORII, S .
EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (11) :900-904
[44]   Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency [J].
Rezaei, Nima ;
Aghamohammadi, Asghar ;
Mahmoudi, Mahdi ;
Shakiba, Yadollah ;
Kardar, Gholam Ali ;
Mahmoudi, Maryam ;
Moradi, Batoul ;
Amirzargar, Ali Akbar .
IMMUNOBIOLOGY, 2010, 215 (01) :81-87
[45]   The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency [J].
Haimila, K. ;
Einarsdottir, E. ;
de Kauwe, A. ;
Koskinen, L. L. E. ;
Pan-Hammarstrom, Q. ;
Kaartinen, T. ;
Kurppa, K. ;
Ziberna, F. ;
Not, T. ;
Vatta, S. ;
Ventura, A. ;
Korponay-Szabo, I. R. ;
Adany, R. ;
Poscai, Z. ;
Szeles, G. ;
Dukes, E. ;
Kaukinen, K. ;
Maki, M. ;
Koskinen, S. ;
Partanen, J. ;
Hammarstrom, L. ;
Saavalainen, P. .
GENES AND IMMUNITY, 2009, 10 (02) :151-161
[46]   Increased IRF4 expression in isolated B cells from common variable immunodeficiency (CVID) patients [J].
Afshar-Ghasemlou, S. ;
Esmaeil, N. ;
Sherkat, R. ;
Yazdani, R. ;
Abbasi-Rad, F. ;
Ganjalikhani-Hakemi, M. ;
Rezaei, A. .
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2019, 47 (01) :52-59
[47]   Reduced Interleukin-5 Production by Peripheral Cd4+T Cells in Common Variable Immunodeficiency Patients [J].
Del Vecchio, Giovanni Carlo ;
Martire, Baldassarre ;
Lassandro, Giuseppe ;
Cecinati, Valerio ;
De Mattia, Delia ;
Ciccarelli, Maria ;
Piacente, Laura ;
Giordano, Paola .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2008, 30 (04) :679-686
[48]   Increase of circulating α4β7+ conventional memory CD4 and regulatory T cells in patients with common variable immunodeficiency (CVID) [J].
de Melo, Karina Mescouto ;
Unger, Susanne ;
Keller, Baerbel ;
Gutenberger, Sylvia ;
Stumpf, Ina ;
Goldacker, Sigune ;
Warnatz, Klaus .
CLINICAL IMMUNOLOGY, 2017, 180 :80-83
[49]   Grouping of patients with common variable immunodeficiency based on immunoglobulin biosynthesis: Comparison with a classification system on CD4-naive cells [J].
Livaditi, Olga ;
Giamarellos-Bourboulis, Evangelos J. ;
Kakkas, Ioannis ;
Kapsimali, Violetta ;
Lymberi, Peggy ;
Papastariades, Chryssa ;
Douzinas, Emmanuel E. .
IMMUNOLOGY LETTERS, 2007, 114 (02) :103-109
[50]   CTLA-4 Expression in CD4+ T Cells From Patients With LRBA Deficiency and Common Variable Immunodeficiency With No Known Monogenic Disease [J].
Azizi, G. ;
Jamee, M. ;
Yazdani, R. ;
Bagheri, Y. ;
Fayyaz, F. ;
Jadidi-Niaragh, F. ;
Abolhassani, H. ;
Aghamohammadi, A. .
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2018, 28 (06) :422-+